{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:35:09Z","timestamp":1790656509819,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203527"],"award-info":[{"award-number":["82203527"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7232105"],"award-info":[{"award-number":["7232105"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.celrep.2025.115584","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T09:12:25Z","timestamp":1744794745000},"page":"115584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immune atlas of pituitary neuroendocrine tumors highlights endocrine-driven immune signature and therapeutic implication"],"prefix":"10.1016","volume":"44","author":[{"given":"Xiaopeng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chufei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya Linda","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.115584_bib1","doi-asserted-by":"crossref","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017-2021","volume":"26","author":"Price","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.celrep.2025.115584_bib2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/jama.2023.5444","article-title":"Diagnosis and Management of Pituitary Adenomas: A Review","volume":"329","author":"Tritos","year":"2023","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.celrep.2025.115584_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO Classification of Pituitary Tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.celrep.2025.115584_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41574-021-00550-w","article-title":"Aggressive pituitary tumours and pituitary carcinomas","volume":"17","author":"Raverot","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.celrep.2025.115584_bib5","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz211","article-title":"Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German Survey","volume":"105","author":"Elbelt","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2025.115584_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-17-0933","article-title":"Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016","volume":"178","author":"McCormack","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.celrep.2025.115584_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","article-title":"Recurrent gain-of-function USP8 mutations in Cushing's disease","volume":"25","author":"Ma","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.celrep.2025.115584_bib8","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1038\/s41467-018-05275-5","article-title":"Identification of recurrent USP48 and BRAF mutations in Cushing's disease","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.115584_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41422-022-00736-5","article-title":"Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors","volume":"32","author":"Zhang","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.celrep.2025.115584_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/endrev\/bnac024","article-title":"Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas","volume":"44","author":"Ilie","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.celrep.2025.115584_bib11","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1210\/clinem\/dgad098","article-title":"Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment","volume":"108","author":"Burman","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2025.115584_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108506","article-title":"Therapeutic targeting of the pituitary tumor microenvironment","volume":"250","author":"Ilie","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.celrep.2025.115584_bib13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/EJE-22-0647","article-title":"Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study","volume":"187","author":"Ilie","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.celrep.2025.115584_bib14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1530\/EJE-22-0440","article-title":"Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients","volume":"187","author":"Burman","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.celrep.2025.115584_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001532","article-title":"Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study","volume":"8","author":"Majd","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celrep.2025.115584_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/jpm10030088","article-title":"Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature","volume":"10","author":"Duhamel","year":"2020","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.celrep.2025.115584_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/cen.14645","article-title":"Should pituitary carcinoma be treated using a NET-like approach? A case of complete remission of a metastatic malignant prolactinoma with multimodal therapy including immunotherapy","volume":"98","author":"Goichot","year":"2023","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.celrep.2025.115584_bib18","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1227\/neu.0000000000002024","article-title":"Complete Response of a Patient With a Mismatch Repair Deficient Aggressive Pituitary Adenoma to Immune Checkpoint Inhibitor Therapy: A Case Report","volume":"91","author":"Shah","year":"2022","journal-title":"Neurosurgery"},{"key":"10.1016\/j.celrep.2025.115584_bib19","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab133","article-title":"Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma","volume":"5","author":"Lin","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.celrep.2025.115584_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.576027","article-title":"Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy","volume":"11","author":"Lamb","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.celrep.2025.115584_bib21","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-20-0151","article-title":"Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment?","volume":"184","author":"Sol","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.celrep.2025.115584_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/CAD.0000000000000856","article-title":"Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab","volume":"31","author":"Caccese","year":"2020","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.celrep.2025.115584_bib23","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1210\/jc.2018-01347","article-title":"Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and Nivolumab","volume":"103","author":"Lin","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2025.115584_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1530\/ERC-22-0037","article-title":"Immunotherapy in aggressive pituitary tumors and carcinomas: a systematic review","volume":"29","author":"Ilie","year":"2022","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.celrep.2025.115584_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174093","article-title":"Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art","volume":"14","author":"Feola","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.celrep.2025.115584_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216908","article-title":"Immune landscape and progress in immunotherapy for pituitary neuroendocrine tumors","volume":"592","author":"Guo","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.celrep.2025.115584_bib27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2016.04.019","article-title":"Mass Cytometry: Single Cells, Many Features","volume":"165","author":"Spitzer","year":"2016","journal-title":"Cellule"},{"key":"10.1016\/j.celrep.2025.115584_bib28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2025.115584_bib29","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","article-title":"Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes","volume":"181","author":"Friebel","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115584_bib30","doi-asserted-by":"crossref","first-page":"76565","DOI":"10.18632\/oncotarget.12088","article-title":"Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors","volume":"7","author":"Mei","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2025.115584_bib31","doi-asserted-by":"crossref","first-page":"e3207","DOI":"10.1210\/clinem\/dgaa449","article-title":"The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness","volume":"105","author":"Wang","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2025.115584_bib32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11060-020-03476-x","article-title":"In silico analysis of the immunological landscape of pituitary adenomas","volume":"147","author":"Yeung","year":"2020","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.celrep.2025.115584_bib33","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/neuonc\/noab102","article-title":"Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors","volume":"23","author":"Cui","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.celrep.2025.115584_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/EJE-21-1183","article-title":"Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior","volume":"187","author":"Zhang","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.celrep.2025.115584_bib35","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41416-022-02126-5","article-title":"Single-cell sequencing of PIT1-positive pituitary adenoma highlights the pro-tumour microenvironment mediated by IFN-gamma-induced tumour-associated fibroblasts remodelling","volume":"128","author":"Lyu","year":"2023","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.celrep.2025.115584_bib36","article-title":"Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET","volume":"4","author":"Zhang","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2025.115584_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-023-01267-3","article-title":"Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors","volume":"16","author":"Yan","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.celrep.2025.115584_bib38","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ccell.2021.06.017","article-title":"Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity","volume":"39","author":"Hutton","year":"2021","journal-title":"Cancer. Cell."},{"key":"10.1016\/j.celrep.2025.115584_bib39","first-page":"2579","article-title":"Visualizing data using t-SNE","volume":"9","author":"L","year":"2008","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.celrep.2025.115584_bib40","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/PAP.0b013e3181bb6bc2","article-title":"Plasmacytoid dendritic cells: physiologic roles and pathologic states","volume":"16","author":"Jegalian","year":"2009","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.celrep.2025.115584_bib41","article-title":"Plasmacytoid Dendritic Cells and Cancer Immunotherapy","volume":"11","author":"Fu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115584_bib42","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.4049\/jimmunol.176.3.1517","article-title":"CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity","volume":"176","author":"Hayakawa","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.115584_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/intimm\/dxn022","article-title":"Application of CD27 as a marker for distinguishing human NK cell subsets","volume":"20","author":"Silva","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.celrep.2025.115584_bib44","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41419-024-06976-0","article-title":"Natural Killer cells at the frontline in the fight against cancer","volume":"15","author":"Coenon","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2025.115584_bib45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.1401553","article-title":"CCR6-dependent positioning of memory B cells is essential for their ability to mount a recall response to antigen","volume":"194","author":"Elgueta","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.115584_bib46","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2017.11.022","article-title":"CCR6 Defines Memory B Cell Precursors in Mouse and Human Germinal Centers, Revealing Light-Zone Location and Predominant Low Antigen Affinity","volume":"47","author":"Suan","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.115584_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T cell lineage differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.115584_bib48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41416-022-02056-2","article-title":"Th2 cells inhibit growth of colon and pancreas cancers by promoting anti-tumorigenic responses from macrophages and eosinophils","volume":"128","author":"Jacenik","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2025.115584_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115976","article-title":"Polysaccharides regulate Th1\/Th2 balance: A new strategy for tumor immunotherapy","volume":"170","author":"Shang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.celrep.2025.115584_bib50","article-title":"CD38 and Regulation of the Immune Response Cells in Cancer","volume":"2021","author":"Dwivedi","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.celrep.2025.115584_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113395","article-title":"CD38: An important regulator of T cell function","volume":"153","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.celrep.2025.115584_bib52","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5114\/ceji.2019.92795","article-title":"CD163 and CCR7 as markers for macrophage polarization in lung cancer microenvironment","volume":"44","author":"Kwiecien","year":"2019","journal-title":"Cent. Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2025.115584_bib53","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41416-020-01037-7","article-title":"Differential association of CD68(+) and CD163(+) macrophages with macrophage enzymes, whole tumour gene expression and overall survival in advanced melanoma","volume":"123","author":"Tremble","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2025.115584_bib54","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/2159-8290.CD-17-1033","article-title":"CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1\/PD-L1 Blockade","volume":"8","author":"Chen","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2025.115584_bib55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/s12967-023-04445-4","article-title":"Decoding meningioma heterogeneity and neoplastic cell-macrophage interaction through single-cell transcriptome profiling across pathological grades","volume":"21","author":"Fan","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.celrep.2025.115584_bib56","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.cell.2017.04.016","article-title":"An Immune Atlas of Clear Cell Renal Cell Carcinoma","volume":"169","author":"Chevrier","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115584_bib57","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115584_bib58","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.cell.2018.08.039","article-title":"A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging","volume":"174","author":"Keren","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.115584_bib59","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/neuonc\/noad017","article-title":"Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma","volume":"25","author":"Wang","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.celrep.2025.115584_bib60","series-title":"Pituitary Function and Immunity","first-page":"1","author":"Berczi","year":"1986"},{"key":"10.1016\/j.celrep.2025.115584_bib61","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bbi.2003.09.014","article-title":"A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines","volume":"18","author":"Dimitrov","year":"2004","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.celrep.2025.115584_bib62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1749-6632.1990.tb40471.x","article-title":"The role of growth hormone in modulation of the immune response","volume":"594","author":"Kelley","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.celrep.2025.115584_bib63","doi-asserted-by":"crossref","first-page":"568","DOI":"10.20945\/2359-3997000000186","article-title":"Growth hormone in the tumor microenvironment","volume":"63","author":"Chesnokova","year":"2019","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2025.115584_bib64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12022-015-9383-6","article-title":"Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas","volume":"26","author":"Lu","year":"2015","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.celrep.2025.115584_bib65","first-page":"610","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"10.1016\/j.celrep.2025.115584_bib66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/cyto.a.23926","article-title":"Automated Data Cleanup for Mass Cytometry","volume":"97","author":"Bagwell","year":"2020","journal-title":"Cytometry A."},{"key":"10.1016\/j.celrep.2025.115584_bib67","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-0716-0327-7_16","article-title":"Immunedeconv: An R Package for Unified Access to Computational Methods for Estimating Immune Cell Fractions from Bulk RNA-Sequencing Data","volume":"2120","author":"Sturm","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.celrep.2025.115584_bib68","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2025.115584_bib69","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s42003-020-01146-2","article-title":"MethylResolver-a method for deconvoluting bulk DNA methylation profiles into known and unknown cell contents","volume":"3","author":"Arneson","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.celrep.2025.115584_bib70","article-title":"UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction","author":"McInnes","year":"2018","journal-title":"arXiv"},{"key":"10.1016\/j.celrep.2025.115584_bib71","doi-asserted-by":"crossref","first-page":"924","DOI":"10.4049\/jimmunol.1501928","article-title":"Categorical Analysis of Human T Cell Heterogeneity with One-Dimensional Soli-Expression by Nonlinear Stochastic Embedding","volume":"196","author":"Cheng","year":"2016","journal-title":"J. Immunol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725003559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725003559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:16:17Z","timestamp":1776834977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725003559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2211124725003559"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.115584","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune atlas of pituitary neuroendocrine tumors highlights endocrine-driven immune signature and therapeutic implication","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.115584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115584"}}